Research location
Concord
California, United States
Advertisement
Research activity in Concord
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 278 trials and 282 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Concord
278 linked trials · page 2 of 6Mylan Insulin Aspart StudyNCT03760068 · 2018-11-07 · 1 site observation
COMPLETED
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsNCT03662204 · 2018-08-23 · 1 site observation
COMPLETED
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast CancerNCT03498716 · 2018-08-02 · 1 site observation
TERMINATED
Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or ObesityNCT03552757 · 2018-06-04 · 1 site observation
COMPLETED
Effect of Efpeglenatide on Cardiovascular OutcomesNCT03496298 · 2018-04-27 · 1 site observation
TERMINATED
e-Diary in Heart FailureNCT03452683 · 2018-04-01 · 1 site observation
WITHDRAWN
Study to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · 2018-03-21 · 1 site observation
COMPLETED
Hemodynamic-GUIDEd Management of Heart FailureNCT03387813 · 2018-03-15 · 1 site observation
COMPLETED
Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® TestingNCT03511235 · 2018-03-12 · 1 site observation
COMPLETED
Technology-Based Intervention to Promote Heart Health After Cardiac Rehab (Mobile4Heart)NCT03446313 · 2018-02-28 · 1 site observation
COMPLETED
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskNCT03315143 · 2017-12-19 · 1 site observation
TERMINATED
Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 DiabetesNCT03268005 · 2017-09-19 · 1 site observation
COMPLETED
Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate CancerNCT03290508 · 2017-09-14 · 1 site observation
TERMINATED
Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin GlargineNCT03211858 · 2017-08-02 · 1 site observation
COMPLETED
A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart FailureNCT03152552 · 2017-07-25 · 1 site observation
TERMINATED
A Study of LY900014 in Participants With Type 1 DiabetesNCT03214367 · 2017-07-17 · 1 site observation
COMPLETED
Glooko mHealth Advantage StudyNCT02974816 · 2017-05-15 · 1 site observation
COMPLETED
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight AdultsNCT03100058 · 2017-05-06 · 1 site observation
COMPLETED
A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic DrugsNCT03078478 · 2017-03-13 · 1 site observation
COMPLETED
Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal InsulinNCT02963922 · 2017-02-06 · 1 site observation
COMPLETED
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 DiabetesNCT02692716 · 2017-01-17 · 1 site observation
COMPLETED
Palbociclib in Real World PracticeNCT03280303 · 2017-01-04 · 3 site observations
COMPLETED
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentNCT02827708 · 2016-09-20 · 1 site observation
COMPLETED
A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment IntensificationNCT02906917 · 2016-09-20 · 1 site observation
COMPLETED
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)NCT02595944 · 2016-07-22 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes MellitusNCT02688933 · 2016-05-05 · 1 site observation
COMPLETED
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 DiabetesNCT02500706 · 2016-05-04 · 1 site observation
COMPLETED
Baroreflex Activation Therapy for Heart FailureNCT02627196 · 2016-04-19 · 1 site observation
COMPLETED
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.NCT02648204 · 2016-01-06 · 1 site observation
COMPLETED
Evaluation of the Accuracy of an Implanted Glucose SensorNCT02647905 · 2016-01-01 · 1 site observation
COMPLETED
Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)NCT02580591 · 2015-12-22 · 1 site observation
COMPLETED
Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential HypertensionNCT02603809 · 2015-12-14 · 1 site observation
COMPLETED
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes MellitusNCT02561078 · 2015-10-20 · 1 site observation
COMPLETED
Bexagliflozin Efficacy and Safety TrialNCT02558296 · 2015-10-01 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKDNCT02547935 · 2015-09-21 · 1 site observation
COMPLETED
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy AloneNCT02531035 · 2015-09-01 · 1 site observation
COMPLETED
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 DiabetesNCT02460978 · 2015-07-08 · 1 site observation
COMPLETED
Dose-ranging Study in Patients With Type 1 Diabetes MellitusNCT02459899 · 2015-07-01 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 DiabetesNCT02413398 · 2015-06-15 · 1 site observation
COMPLETED
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)NCT02201992 · 2015-03-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)NCT02193282 · 2015-02-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin GlargineNCT02273180 · 2014-10-01 · 1 site observation
COMPLETED
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738 · 2014-09-26 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of LY2623091 in Participants With High Blood PressureNCT02194465 · 2014-08-01 · 1 site observation
COMPLETED
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 DiabetesNCT02098395 · 2014-05-01 · 1 site observation
COMPLETED
A Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM)NCT02139943 · 2014-05-01 · 1 site observation
COMPLETED
A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy RegimenNCT02066636 · 2014-04-09 · 1 site observation
COMPLETED
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 DiabetesNCT02119819 · 2014-04-01 · 1 site observation
COMPLETED
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic GastroparesisNCT02025751 · 2014-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.